DEVICE CATEGORY · OWO
Drug-Eluting Sinus Stent
Mechanically maintain patency following ethmoid sinus surgery. By also eluting drugs, reduce the need for post-operative intervention such as surgical adhesion lysis and/or use of oral steroids.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Propel Family ProductsP100044/S060 | Intersect Ent. | PMA supplement | Sep 23, 2026 | FDA |
PROPELP100044/S061 | Intersect Ent. | PMA supplement | Sep 22, 2026 | FDA |
PROPELP100044 | Intersect Ent. | PMA approval | Aug 11, 2011 | FDA |
Source information
Follow the FDA links to view the original records.

